Our findings in the Japanese population, in combination with previous genetic and clinical findings, suggest that the aldosterone synthase gene (CYP11B2) may be a potential causal gene for resistant hypertension, and support the important role of aldosterone and its pathways in the pathophysiology of resistant hypertension, the same as for hypertension. Here, CYP11B2 is linked to hypertensive disorder.